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Abstract 
Purpose: To determine the effect of the secondary metabolites from Penicillium sp. H9318 on 
cytotoxicity and cell cycle progression.  
Methods: A yeast PP1 inhibitory screening system was carried out to confirm the presence of anti-
PP1c activity in crude acetone extracts of strain H9318. The extracts were fractionated and identified as 
Fraction S1 and Citrinin 9318 (CTN9318). Various cancer cell lines were used to test for the toxicity of 
the crude acetone extracts, Fraction S1 and Citrinin 9318, using MTT viability assay.  
Results: It was found that a colorectal cancer cell line, HT-29, was susceptible to Fraction S1 and 
Citrinin 9318. A propidium iodide (PI)-incorporated DNA assay was used to show that there was G2/M 
arrest in HT-29 by Citrinin 9318.  
Conclusion: Citrinin 9318 inhibits the viability of HT-29 via mitotic block. The results suggest that 
Citrinin 9318 is capable of exerting cytotoxicity and mitotic arrest in a colon cancer cell line, HT29. 
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Microfungi H9318 has been identified as a 
Penicillium sp. isolated from the soil under 
leaflets at Maliau Basin, Sabah reserved forest. 
Preliminary experiments showed that ethyl 
acetate extracts from H9318 strain contain a 
PP1-inhibitory component (Fraction S1) that is 
useful for the study of the mode of action of 
H9318 strain when exposed to cancer cell lines. 
  
PP1 is one of the serine/threonine protein 
phosphatases belonging to the PPP gene family 
which is abundantly expressed in animal cells 
and is able to manipulate cell cycle and 
apoptosis. Various natural inhibitors for PP1, 
okadaic acid and calyculin A, have been 
discovered to disrupt cell cycle and progressed 
into apoptosis in an oncogenic transformed and 
epithelial tumour lines [1,2].  
 
Citrinin (CTN) is a mycotoxin found in food and 
feed as a contaminant and it can cause 
nephrotoxicity and genotoxic to animal and yeast 
cells [3,4]. Other studies have shown that CTN is 
also capable to induce cell cycle arrest in a 
mouse skin [5] and apoptosis in HL-60, a human 
promyelocytic leukemia cell line. CTN9318 was 
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isolated from H9318 strain but in contrast to 
Fraction S1, it did not yield anti-PP1c effect. 
CTN9318 has a similar structure with the 
commercially available Citrinin. The objectives of 
our studies were to find out whether anti-PP1 
effect of Fraction S1 could trigger cell cycle 
arrest and the potential genotoxic effect of 
CTN9318 on the induction of cell cycle arrest on 




Microfungi culture and preservation 
 
Microfungi H9318 was cultured in a Potato 
dextrose agar (PDA). PDA medium was 
prepared by adding 2 g of the PDA powder 
(Merck) into 50 ml of distilled water and 
autoclaved at 121 oC for 20 min. Agar medium 
(25 mL) was poured into a Petri dish with 25 mL 
and left to harden before inoculation. Conidia of 
the H9318 strain were streaked onto the surface 
of the agar using a sterile inoculating wire loop 
and incubated at 25 oC to yield single colony. 
After 5 days of incubation, greenish and powdery 
appearance of the cultures indicated mature 
growth of the microfungi. Cultures were sub-
passaged onto a slant agar and kept at 4 oC for 
future experimental use. Conidia were 
transferred to a Bijou bottle containing sterile 
water kept at 4 oC for short term storage and also 
transferred to a slant agar kept at -20 oC for long 
term storage. 
 
Fermentation culture of H9318 strain 
 
Fermentation of H9318 was done in the 
laboratory with the YPD liquid medium to yield 
secondary metabolites. The YPD liquid medium 
consists of yeast extracts (Sigma), Peptone 
enzymatic digested from meat (Fluka), Sucrose 
(Amresco), KH2PO4 (Fluka) and MgSO4.7H2O 
(Amresco) with a pH of 5.5. The medium (25 mL) 
was poured into 100 mL conical flasks and 
cotton-sealed prior to autoclaving. Then, conidia 
of H9318 were inoculated into each conical flask 
and placed in a refrigerated shaking incubator 
(IS-971R, Lab Companion, Jeio Tech Inc.) at 28 
oC, 220 rpm for 120 h. 
 
At day 5 (120 h), cultures were filtered through a 
filter paper (Whatman No.1) by using a glass 
funnel and collected into 1 L Erlenmeyer flask. 
Acetone was added into the culture medium at 
1:1 ratio. Acetone breaks cell wall and plasma 
membrane besides extracting bioactive 
secondary metabolites. The mixture was gently 
swirled and kept at 4 oC for 3 days to ensure a 
complete extraction. Next, acetone was 
evaporated from the mixture using Eyela rotary 
evaporator N-1000, Eyela oil bath OSB-2000, 
Eyela pump A-1000S, at 42 oC. The remaining 
liquid subjected to freeze drying to collect the 
crude freeze-dried acetone extract. 
 
Equal volume of ethyl acetate was poured into 
the crude acetone extract, gently swirled and 
kept at 4 oC for 3 days. This step was called 
liquid-liquid extraction (LLE) that is to separate 
particles into the organic or the water layer 
extracts. After 3 days, two visible immiscible 
layers were observed and the ethyl acetate layer 
was separated out by a glass separator and the 
ethyl acetate layer extract was evaporated using 
a rotary evaporator at 42 oC. The process of 
evaporation ceased when brownish extracts 
were observed on the collecting flask. 
 
HPLC collection and fractionation of Fraction 
S1 
 
The purified ethyl acetate extracts were 
dissolved in 100 % methanol and filtered through 
a microporous membrane filter (Acrodisc LC, 
0.20 µm, 13 mm, GHP, PALL) into an amber 
screw neck vial 12 x 32 mm with bonded 
PTFE/Silicone membrane. The vial was put into 
the HPLC machine and the sample analytes (50 
µL) were injected into the machine.  
 
The HPLC machine consists of Waters 2695 
Separation Module, Waters 2487 UV detector 
channel and Waters Fraction Collector II. A semi-
preparative reverse phase column (Licospher 
C18, Merck) was used with a flow rate of 5 
ml/min. A running time of 15 – 30 min was set 
with an isocratic mode using acetonitrile and 
water which were programmed at the ratio of 




Collected fractions from HPLC were pooled in 
Eppendorf tubes and distilled water added in 
order to allow the fractions to be frozen. The 
Eppendorf tubes were put into the freeze-drying 
flasks and stored at -80 oC overnight before 
placing in the freeze-dryer (Telstar).  
 
Freeze-drying process was performed in a 
lyophilization equipment which consists of a 
drying chamber with temperature controlled 
shelves, a condenser to trap water removed from 
the product, a cooling system to supply 
refrigerant to the shelves and condenser, and a 
vacuum system to reduce pressure in the 
chamber and condenser to facilitate the drying 
process. The freezing condition was a 
prerequisite from the solid phase to gas phase at 
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low pressure. Freeze-dried fractions were kept at 
-20 oC to avoid degradation.  
 
Preparation of treatments 
 
Crude freeze-dried acetone extract was 
dissolved in RPMI medium. Fraction S1 from 
HPLC elution at 4 min as in Ong et al [6] was 
dissolved in less than 0.5 % of DMSO and 
diluted with RPMI 1640 medium upon cell 
treatment. CTN9318 was dissolved in < 0.5 % of 
ethanol and DMSO, was then diluted with RPMI 
1640 medium. All the samples were filtered 
through microporous membrane filters (PES 
membrane, 0.22 µm, Millipore) and kept at -20 
oC.  
 
Yeast PP1 inhibitory screening system 
 
Yeast testers, Saccharomyces cerevisiae – 
H10018, a wild-type yeast carrying a GLC gene 
encoding for PP1c, or was designated as 
PAY704-1 and H10017, a mutant yeast carrying 
a high temperature sensitive allele, glc-10, or 
was designated as PAY700-4. Were used for 
screening both types of yeasts were grown in a 
Yeast Peptone Dextrose (YPD) medium. Yeasts 
were cultured in a sterile liquid medium (YPD) at 
25 oC in a refrigerated shaking incubator and 
agitated at 220 rpm. After 3 days of incubation, 
100 µL of the yeasts were added into a 25 mL of 
YPD agar and were poured into a Petri dish. 
After that, a 6 mm paper disc was soaked with 
the treatment fraction and was placed onto the 
surface of YPD agar. After all the paper discs 
were arranged on the agar, the Petri dishes were 
incubated at 25 and 37 oC. After 3 days, 




Breast (MCF-7 and MDA-MB-231), 
nasopharyngeal (CNE1, TWO1 and TWO4), 
cervical (Hela), ovarian (CaOV3), prostate (PC3) 
and colorectal cancer (HT-29) cell lines were 
obtained from ATCC. Cells were grown in RPMI 
1640 medium (Gibco) supplemented with 10 % 
FBS and 1 % penicillin/streptomycin (Gibco). 
Cells were cultured and propagated at 37 oC in a 
CO2 incubator with 5 % CO2 in a humidified 
atmosphere.  
 
Cell count after trypsinization for bioassays  
 
HT-29 cells were trypsinized with 0.25 % of 
Trypsin-EDTA (Gibco) after 80 % confluency. 
Then, the suspension of cells was diluted with 
Trypan blue dye and counted using a 
haemocytometer. Cells were visualized and 
counted under a phase-contrast microscope. 
MTT viability assay 
 
Seven cell lines were harvested and treated with 
two-fold serial dilutions of Fraction S1 (400 
µg/mL) and CTN9318 (50 µg/mL) in three 
separate experiments as shown in Fig. 3. Each 
triplicate of the treatments was compared to the 
corresponding untreated controls. Next, 10 µL of  
MTT solution (5 mg/mL) was added into each 
well using a multichannel pipette and incubated 
for 4 h in a CO2 incubator. Then, the liquid in 
each well was discarded and the formazan 
crystals were solubilized with 100 µL of DMSO. 
The microplate was mixed properly and 
absorbance was measured using an ELISA 
reader (DYNEX Technologies MRX11) at 570 nm 
wavelength. Experiments were repeated at least 
three times and data were expressed as percent 
cell viability against the concentrations (µg/mL).  
 
PI-incorporated DNA assay 
 
Mitotic arrest was determined by using the 
Propidium iodide (PI) staining intercalated with 
the DNA content in a cell and analyzed by a flow 
cytometer, FACSCalibur (Becton Dickinson). HT-
29 cells with a concentration of 1.5 x 105 cells/mL 
were seeded into a 24-well plate and incubated 
overnight. Cells were exposed to 50 and 200 
µg/mL of Fraction S1 and 1, 5 and 10 µg/mL of 
CTN9318. After 24 h of incubation, the cells were 
harvested and washed with PBS/0.3 % of BSA 
and were pelleted at 2000 rpm, 5 min. Later, the 
pellets were fixed with ice-cold 70 % of ethanol 
and kept overnight. The next day, the fixed cells 
were washed and stained with PI after adding 
RNase solution. Percent of the PI-stained cells 
(10,000 gated single cells) were calculated using 




Statistical analysis was performed using 
Student’s t-test (SPSS version 12.0) to evaluate 
differences between treated and untreated 
groups. Statistical significance was defined as p 




Yeast PP1 inhibition 
 
The viability of two Saccharomyces cerevisiae 
strains, H10017 and H10018 were tested using 
ethyl acetate extracts from strain H9318. This 
assay system was carried out to determine 
whether the extracts from strain H9318 could 
inhibit PP1c. 
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H10017, also known as PAY700-4, is a mutant 
yeast. It contains a temperature sensitive allele 
glc7-10 which cannot survive at the restrictive 
temperature of 37 oC. H10018, also known as 
PAY704-1, is a wild-type yeast that carries a 
normal GLC gene encoding PP1c. Our results 
show that ethyl acetate extract from H9318 strain 
killed the wild type yeast, H10018 at 37 oC in a 
dose-dependent manner (Figure 1A). The higher 
the amount of the extract, the higher the number 
of H10018 killed. There was a clear inhibition 
zone indicated with arrow. As compared to Petri 
dish C, there was no inhibition zone observed at 
25 oC, showing that the extract inhibited PP1c 
specifically. This result is compatible with the 
other researchers in the Yeast PP1 screening 
assay which sets a key point for our laboratory to 
reproduce the extracts for our next bioassay 
experiments [6]. 
 
Fraction S1 and CTN9318 
 
The ethyl acetate extract was dissolved in 100 % 
methanol and 10 µL was injected into the semi-
preparative column. The running time was 15 
min in order to have a maximum display of the 
peaks separated by the HPLC column. There 
were five prominent peaks observed in the 
chromatogram (1, 2, 3, 4 and 5 as indicated in 
Figure 2A) between the running time from 0 to 10 
min. The highest peak detected at 4 – 4.5 min 
was designated as Fraction S1 (indicated as 2 in 
the chromatogram). No contaminant occurred as 
methanol did not contain substance that would 
be detected or separated by HPLC. The 
chromatogram was compatible with Ong et al as 
Fraction S1 was eluted at 4 min [6]. Figure 2B 
shows a single and prominent peak of CTN9318 
compared at different wavelengths. It was 
ascertained as a pure compound isolated from 
H9318 strain which possessed a similar structure 
to Citrinin available in the market. Structural 
determination was done by Dr. Chang’s student. 
CTN9318 is a gift from Dr. Leng Chee Chang of 
Hawaii University. 
 
Cell viability  
 
Cell viability of various cancer cell lines was 
calculated using crystal violet formazan dye as 
detected at 570 nm by an ELISA reader. The 
MTT assay shows that Fraction S1 inhibited HT-
29 with an IC50 ~ 50 µg/mL (Figure 3A). IC50 for 
MCF-7, TWO1 and Hela were 80 µg/mL, 110 
µg/mL and 180 µg/mL in response to Fraction 
S1. This is the first report for the cytotoxic results 
of Fraction S1 on cancer cell lines. CTN9318 
exerted a lower IC50 with ~ 18 µg/mL on HT-29 
(3-fold lower than Fraction S1) if compared to 
Fraction S1. The cytotoxic effect of CTN9318 on 
cancer cell lines could also be found on the 
report of the other laboratory [7] which has 
highlighted the IC50 of CTN9318-treated MCF-7 
at 18 µg/mL similar with our cytotoxic data. The 
highest concentration used in CTN9318 was 8-
fold lower than that for Fraction S1, showing that 
CTN9318 was more potent than Fraction S1 
(Figure 3B). 
 
Figure 1: Protein phosphatase 1 catalytic subunit inhibition by ethyl acetate extracts from H9318 on (A) H10018 
at 37 0C, (B) H10017 at 37 0C, (C) H10018 at 25 0C and (D) H10017 at 25 0C.  The doses of ethyl acetate 
extracts were 60 µL (1), 100 µL (2), 200 µL (3) and 360 µL (4). Arrow, indicates clear zone 
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Figure 2: Fractionation of ethyl acetate extract from Penicillium H9318 by HPLC. (A) Chromatogram for Fraction 
S1. (B) Chromatogram for Citrinin H9318 
 
Figure 3: MTT viability assay was measured by 
treating different cancer cell lines with crude freeze-
dried acetone extract (A), Fraction S1 (B) and Citrinin 
H9318 (C). Experiments were repeated at least 3 
times.  MDA-MB-231,  Hela,  HT-29,  
TWO1,  MCF-7 
 
PI-incorporated DNA  
 
Figure 4 shows that PI staining was detected by 
a FL-2 detector in BD FACSCalibur. The DNA 
content was calculated as % for the gated HT-29 
cells. CTN9318 arrested HT-29 at G2/M phase 
after 24 h of incubation at 1, 5 and 10 µg/ml 
(Figure 4B). It shows a dose-dependent 
increment of the PI-stained DNA cells at G2/M 
phase. For other studies, Citrinin (12.5 µg/ml)  
could trigger a 36.7 % increase of sub-G1 HL-60 
cells together with our PI-incorporated DNA 
assay [8], we determined that CTN9318 was 
genotoxic to cancer cell line HT29 and HL60.   
Fraction S1 did not exert cell cycle arrest as 




Yeast PP1 inhibitory screening system has 
shown the presence of PP1c inhibitors from the 
extracts of strain H9318. The ethyl acetate 
extracts of H9318 strain contain anti-PP1c 
property. PP1c is important for the yeasts to 
survive in YPD media as it is utilized by both the 
mutant H10017 and wild-type H10018 to mediate 
a signaling pathway for cell-wall integrity which is 
essential for yeast survival [9]. However, the 
glc7-10 allele of H10017 does not permit survival 
at the high temperature of 37 oC as shown by Fig 
1B because the cell wall integrity is disrupted at 
37 oC.  
 
To ascertain specificity, a control set at 25 oC is 
needed. It is of utmost importance that ethyl 
acetate extracts from strain H9318 do not yield 
positive results (shown by the appearance of 
inhibition zones) on yeast H10018 at 25 oC. This 
is due to the fact that at 25 oC, there are more 
than one cell wall integrity pathways such as the 
bck1 and Mpk1 signalling pathways that enable 
survival of yeasts on agar besides the PP1c-
regulated pathway. The appearance of inhibition  
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Figure 4: Cell cycle analysis by treating HT-29 using Fraction S1 (A) and Citrinin H9318 (B) at 24 h of incubation. 
Experiments were repeated three times independently. p < 0.01 (**). 
 
zone at 25 oC means that the screening result is 
negative for PP1c inhibitors as only the 
disrupters of PP1c signaling pathway are 
selected for the next phase of the study.  
 
After the preliminary screening for anti-PP1c, the 
biological effect of crude acetone extracts on 
various cancer cell lines was investigated. The 
MTT assay results had shown that HT-29 cells 
were inhibited by both Fraction S1 and CTN9318 
in a dose-dependent manner. The morphological 
appearance of HT-29 cells treated with CTN9318 
was round, bright and still adherent while it was 
irregular in shape and dull when treated with 
Fraction S1 (data not shown). Thus, this 
indicated that the effect of Fraction S1 and 
CTN9318 from H9318 strain was different. 
 
For the cell cycle analysis, HT-29 treated with 
CTN9318 was arrested at G2/M phase and 
CTN9318 was genotoxic to HT-29 cells. Further 
evaluation needs to be carried out to determine 
which cell cycle proteins were affected by the 
treatment of CTN9318 and the stark difference in 
the activity of Citrinin on the cell cycle 
progression of HL60 and HT-29 shows that 
CTN9318 might contribute to premature mitosis 
of the adhered HT-29 cells rather than the 
suspended HL60 cells. Fraction S1 failed to 
trigger a G2/M arrest in HT-29 showing that PP1 
inhibition is not necessary for the mitotic 
disruption in the event for cell death. Further 
studies on involvement of the other proteins in 
the mitotic arrest induced by CTN9318 and 
mechanism of cell death induced by Fraction S1 
needs to be carried out. 
CONCLUSION 
 
The findings of this study indicate that ethyl 
acetate extract of H9318 strain Penicillium 
contains a PP1c inhibitor, Fraction S1. The 
results also show that the genotoxicity of 
CTN9318 can arrest HT-29 at G2/M phase and 
the possible PP1-inhibitory cell death mechanism 
triggered by Fraction S1 on HT-29 does not 
involve cell cycle arrest at G2/M phase. In a 
future study, efforts will be made to combine the 
two extracts isolated from H9318 strain on HT-29 
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